InsiderTrades

Form 4 for BEAM Beam Therapeutics Inc.

Accepted 2023-11-22 00:00:00 ET · period of report 2023-11-20 · accession 0000950170-23-065868 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMT 2023-11-22 2023-11-20 BEAM Bellon Christine CLO S - Sale+OE $30.50 -10.0K 87.4K -10% -$305.0K
DMT 2023-11-22 2023-11-20 BEAM Bellon Christine CLO M - OptEx $7.22 +10.0K 86.6K +13% +$72.2K
DMT 2023-11-22 2023-11-20 BEAM Bellon Christine CLO M - OptEx $0.00 -10.0K 10.9K -48% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-11-20 S D 5,000 $31.00 82,402 D — —
2 Common Common Stock 2023-11-20 S D 5,000 $30.00 87,402 D — —
3 Common Common Stock 2023-11-20 M A 5,818 $7.22 92,402 D — —
4 Common Common Stock 2023-11-20 M A 4,182 $7.22 86,584 D — —
5 Derivative Stock Option (Right to Buy) 2023-11-20 M D 4,182 $0.00 9,492 D $7.22 · — to 2029-05-16 4,182 Common Stock (F2) The option vests as to 25% on the first anniversary of the vesting commencement date, May 16, 2020, and at a rate of 2.78% each month thereafter until the option is fully vested.
6 Derivative Stock Option (Right to Buy) 2023-11-20 M D 5,818 $0.00 10,918 D $7.22 · — to 2029-05-17 5,818 Common Stock (F3) The option vests as to 25% on the first anniversary of the vesting commencement date, May 17, 2020, and at a rate of 2.78% each month thereafter until the option is fully vested.